Guillaume Pfefer, CEO of Sail Biomedicines and CEO-Partner at Flagship Pioneering, explains how the company’s platform is unlocking fully programmable medicines and shares more on two recently announced partnered programs targeting malaria and cystic fibrosis. More from Flagship @ JPM2024 here.
Related Companies
- Sail Biomedicines Founded: 2017 / 2023
